B Cell Lymphoma
News
Two immunologists receive Nobel Prize in medicine
Two immunologists have been awarded the Nobel Prize in Physiology or Medicine for discoveries that represent a “paradigmatic shift in the fight...
News
FDA lifts partial hold on tazemetostat trials
The partial hold that paused U.S.-based enrollment in clinical trials of tazemetostat has been lifted.
Conference Coverage
Prognostic factors guide mantle cell treatment decisions
CHICAGO –
Conference Coverage
CAR T-cell studies dominate ongoing cellular therapy trials
Out of 753 cellular therapy trials listed at ClinicalTrials.gov as of March 30, 2018, 404 were CAR T therapy studies.
News
FDA lifts partial hold on tazemetostat trials
The U.S.
News
Outpatient lenalidomide/rituximab yields long-term MCL remission
Nearly two-thirds of evaluable patients with mantle cell lymphoma had durable responses to induction and maintenance.
News
NICE looks likely to reject use of Kymriah for DLBCL
The U.K. agency issued draft guidance recommending against use of tisagenlecleucel (Kymriah) a month after issuing similar guidance about...
News
AYA cancer: Bridging the divide
There is a wide range of efforts and collaborations aimed at finally correcting the disparities in survival among adolescents and young adults...
News
CK and TP53 status should be assessed together, team says
Researchers say they have found evidence to suggest that patients with mantle cell lymphoma (MCL) should be evaluated for TP53 mutation and...
News
NICE rejects DLBCL indication for CAR T-cell therapy
The National Institute for Health and Care Excellence (NICE) has issued a draft guidance saying it cannot recommend tisagenlecleucel (Kymriah) as...